Quick Stats

Bid Price GBX 136.30 Offer Price GBX 136.60
Mid Price - Day Change GBX +0.10 (0.07%)
Price Date 20 Oct 2017 Crown Rating 3
Shares Class Inc. Yield 0.46 %
Total Expense Ratio 0.00 Fund Size 230,014,700.00
Launch Date 22/05/2000 Standard Initial Charge (%) 0.00
Currency GBX ISA Eligible No
Annual Management Charge (%) 0.75 Sector IMA UK Equity Income
Min Investment (£) 1,000,000.00 Total Expense Ratio (%) 0.00
ISIN GB00B76V7R15 Min TopUp (£) 100,000.00

Fund Objective

The fund's investment objective is to achieve capital growth. The fund will invest in healthcare, medical services and related products and companies on a world wide basis. Investment will be in directly held transferable securities. The fund may also invest in collective investment schemes, warrants and money market instruments.

Fund Managers

John Bowler
John Joined Schroders in 2003.Investment career commenced in 1994.Currently Global Sector Specialist with responsibility for the healthcare sector and manager of the Schroder Medical Discovery Fund, as well as having primary research responsibility for Pan-European pharmaceuticals. Based in London John joined Schroders from AXA Investment Managers, where he had worked since 1998 in a global healthcare research role. He was voted top buy-side analyst for the pharmaceutical and healthcare sector in the Institutional Investor Pan European Equity survey in 2002.Before this, John worked at State Street Research & Management from 1997 as a fund manager / analyst.Earlier, John joined Hill Samuel Asset Management in 1994 as a graduate trainee, later becoming a junior fund manager for UK equities.Institute of Investment Management and Research (IIMR) qualified. Member of the CFA Society of the UK (CFA UK). PhD in Biochemistry & Physiology, from the University of Manchester. Degree in Biology from the University of Manchester.